4//SEC Filing
Abbhi Sankesh 4
Accession 0001104659-20-044267
CIK 0001137883other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 6:12 PM ET
Size
8.3 KB
Accession
0001104659-20-044267
Insider Transaction Report
Form 4
Abbhi Sankesh
Director
Transactions
- Award
Common Stock
2020-04-06+4,657→ 4,657 total
Holdings
- 2,117,751(indirect: By LLC)
Common Stock
- 250,000(indirect: By LLC)
Warrant to Purchase Common Stock
Exercise: $15.00From: 2020-03-06Exp: 2023-03-06→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on the one month anniversary of the date of grant until fully vested on the 12 month anniversary of the date of grant, provided that the Reporting Person remains a member of the Board of Directors of the Issuer on each vesting date.
- [F2]Abbhi Investments, LLC is the record owner of these securities. Mr. Sankesh Abbhi is the manager of Abbhi Investments, LLC and maintains sole voting and investment power with respect to common stock and warrants held by Abbhi Investments, LLC.
- [F3]Pursuant to the March 6, 2020 Securities Purchase Agreement between Abbhi Investments, LLC and the Issuer, for an aggregate purchase price of $10,000,000, Abbhi Investments, LLC received 1,250,000 shares of Common Stock and a Warrant for 250,000 shares of Common Stock with a purchase price per share of $15.00, and an expiration date of the third anniversary of the date of issuance.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001806887
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 6:12 PM ET
- Size
- 8.3 KB